PE20091724A1 - Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7 - Google Patents
Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7Info
- Publication number
- PE20091724A1 PE20091724A1 PE2009000537A PE2009000537A PE20091724A1 PE 20091724 A1 PE20091724 A1 PE 20091724A1 PE 2009000537 A PE2009000537 A PE 2009000537A PE 2009000537 A PE2009000537 A PE 2009000537A PE 20091724 A1 PE20091724 A1 PE 20091724A1
- Authority
- PE
- Peru
- Prior art keywords
- modulators
- alpha
- trifluoromethyl
- methyl
- nicotine receptor
- Prior art date
Links
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 3
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical group F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- QFHVHZJGQWMBTE-UHFFFAOYSA-N 2-(trifluoromethyl)-1h-indole Chemical compound C1=CC=C2NC(C(F)(F)F)=CC2=C1 QFHVHZJGQWMBTE-UHFFFAOYSA-N 0.000 abstract 1
- 208000028698 Cognitive impairment Diseases 0.000 abstract 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 102000015296 acetylcholine-gated cation-selective channel activity proteins Human genes 0.000 abstract 1
- 108040006409 acetylcholine-gated cation-selective channel activity proteins Proteins 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
REFERIDA A UN DERIVADO DE INDOL DE FORMULA (I), DONDE R1 ES H O ALQUILO C1-C3; R2 ES H, HALO O CIANO; R3 ES PIRIDINA SUSTITUIDA CON Ra; Ra ES HALO, ALQUILO C1-C6, ALCOXI C1-C6, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: N-[(2-TRIFLUOROMETIL-1H-INDOL-5-IL)METIL]-5-(TRIFLUOROMETIL)-2-PIRIDINACARBOXAMIDA, 6-BROMO-N-{[2-(TRIFLUOROMETIL)-1H-INDOL-5-IL]METIL}-3-PIRIDINACARBOXAMIDA, N-[(1-METIL-2-TRIFLUOROMETILINDOL-5-IL)METIL]-5-(TRIFLUOROMETIL)-2-PIRIDINACARBOXAMIDA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES DEL RECEPTOR NICOTINICO DE ACETILCOLINA ALFA 7 (nAChR)ALFA7 Y SON UTILES EN EL TRATAMIENTO DE TRANSTORNOS PSICOTICOS, DETERIORO COGNITIVO, DEPRESION, ENTRE OTROS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0807050A GB0807050D0 (en) | 2008-04-17 | 2008-04-17 | Novel compounds |
| GB0810229A GB0810229D0 (en) | 2008-06-04 | 2008-06-04 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20091724A1 true PE20091724A1 (es) | 2009-12-06 |
Family
ID=40791353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2009000537A PE20091724A1 (es) | 2008-04-17 | 2009-04-16 | Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8283365B2 (es) |
| EP (2) | EP2279184B1 (es) |
| JP (2) | JP2011516598A (es) |
| KR (2) | KR20100133016A (es) |
| CN (2) | CN102066357B (es) |
| AR (1) | AR071203A1 (es) |
| AU (2) | AU2009237650B2 (es) |
| BR (2) | BRPI0911682A2 (es) |
| CA (2) | CA2721630A1 (es) |
| CL (1) | CL2009000916A1 (es) |
| EA (2) | EA018113B1 (es) |
| ES (2) | ES2392796T3 (es) |
| IL (2) | IL208574A (es) |
| MX (2) | MX2010011358A (es) |
| PE (1) | PE20091724A1 (es) |
| TW (1) | TW201004939A (es) |
| UY (1) | UY31769A1 (es) |
| WO (2) | WO2009127679A1 (es) |
| ZA (2) | ZA201006855B (es) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009050186A1 (en) | 2007-10-18 | 2009-04-23 | Janssen Pharmaceutica Nv | Trisubstituted 1,2,4-triazoles |
| JO2784B1 (en) | 2007-10-18 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | 5,3,1 - Triazole substitute derivative |
| WO2009097306A1 (en) * | 2008-01-30 | 2009-08-06 | Cephalon, Inc. | Substituted pyridazine derivatives which have histamine h3 antagonist activity |
| MY152486A (en) | 2008-03-19 | 2014-10-15 | Janssen Pharmaceutica Nv | Trisubstituted 1,2,4 - triazoles as nicotinic acetylcholine receptor modulators |
| CL2009001125A1 (es) | 2008-05-09 | 2011-02-11 | Janssen Pharmaceutica Nv | Compuestos derivados de pirazol trisustituido, moduladores alostericos positivos de los receptores ach nicotinicos; composicion farmaceutica que los comprende; proceso de preparacion de la composicion; y su uso en el tratamiento de enfermedades de snc o inflamatorias. |
| AU2010238518A1 (en) * | 2009-04-16 | 2011-12-01 | Proximagen Limited | Indole derivative modulators of the alpha 7 nAChR |
| TWI558398B (zh) | 2009-09-22 | 2016-11-21 | 諾華公司 | 菸鹼乙醯膽鹼受體α７活化劑之用途 |
| GB201012686D0 (en) * | 2010-07-28 | 2010-09-15 | Glaxo Group Ltd | Novel compounds |
| JO3078B1 (ar) * | 2009-11-27 | 2017-03-15 | Janssen Pharmaceutica Nv | مورفولينوثيازولات بصفتها منظمات الوستيرية نوع الفا 7 موجبة |
| WO2012104782A1 (en) | 2011-02-03 | 2012-08-09 | Lupin Limited | Pyrrole derivatives used as modulators of alpha7 nachr |
| MA34957B1 (fr) | 2011-02-23 | 2014-03-01 | Lupin Ltd | Derives heteroaryle a titre modulateurs des nachr alpha 7 |
| BR112013023813A2 (pt) * | 2011-03-18 | 2016-12-13 | Novartis Ag | combinações de ativadores do receptor acetilcolina nicotínico alfa 7 e antagonistas de mglur5 para uso em dopamina induzida por discinesia na doença de parkinson |
| JP2014509641A (ja) | 2011-03-31 | 2014-04-21 | ルピン・リミテッド | アルツハイマー病やパーキンソン病などの神経変性疾患の治療に用いられるニコチン性アセチルコリン受容体モジュレータとしてのピロール誘導体 |
| TW201245185A (en) | 2011-04-01 | 2012-11-16 | Lundbeck & Co As H | New positive allosteric modulators of nicotinic acetylcholine receptor |
| ES2606043T3 (es) | 2011-07-05 | 2017-03-17 | Lupin Limited | Derivados de biarilo como moduladores de nAChR |
| EP2822946A1 (en) | 2012-03-06 | 2015-01-14 | Lupin Limited | Thiazole derivatives as alpha 7 nachr modulators |
| AU2013259565A1 (en) * | 2012-05-08 | 2014-11-13 | Anvyl Llc | Alpha 7 nicotinic acetylcholine receptor allosteric modulators, their derivatives and uses thereof |
| US20150259344A1 (en) * | 2012-10-02 | 2015-09-17 | Dainippon Sumitomo Pharma Co., Ltd. | Imidazole derivative |
| US20150299178A1 (en) | 2012-11-12 | 2015-10-22 | Lupin Limited | Thiazole Derivatives as Alpha 7 NACHR Modulators |
| CN103006642B (zh) * | 2013-01-04 | 2014-10-22 | 中国药科大学 | 一类炔亚甲基吲哚-2-酮类衍生物的用途 |
| EP2945941B1 (en) | 2013-01-16 | 2016-12-07 | Lupin Limited | Pyrrole derivatives as alpha 7 nachr modulators |
| US10058310B2 (en) | 2013-03-13 | 2018-08-28 | Ethicon Llc | Electrosurgical device with drum-driven articulation |
| WO2014141091A1 (en) | 2013-03-13 | 2014-09-18 | Lupin Limited | Pyrrole derivatives as alpha 7 nachr modulators |
| TW201446243A (zh) | 2013-06-03 | 2014-12-16 | Lupin Ltd | 4-(5-(4-氯苯基)-2-(2-環丙基乙醯基)-1,4-二甲基-1氫-吡咯-3-基)苯磺醯胺作為α7尼古丁乙醯膽鹼受體調節劑 |
| EP3010899A1 (en) | 2013-06-17 | 2016-04-27 | Lupin Limited | Pyrrole derivatives as alpha 7 nachr modulators |
| US20170182058A1 (en) * | 2014-03-25 | 2017-06-29 | Emicipi Llc | Treatment of rett syndrome |
| JP6870304B2 (ja) * | 2016-12-05 | 2021-05-12 | 住友電気工業株式会社 | 半導体装置の製造方法 |
| JP7120549B2 (ja) * | 2016-12-15 | 2022-08-17 | 小野薬品工業株式会社 | Ｔｒｅｋ（ｔｗｉｋ関連ｋチャネル）チャネルのアクチベータ |
| HU231414B1 (hu) | 2018-07-13 | 2023-08-28 | Richter Gedeon Nyrt. | Tiadiazin származékok |
| HU231478B1 (hu) | 2018-07-13 | 2024-02-28 | Richter Gedeon Nyrt. | Szubsztituált (aza)indol származékok |
| HU231333B1 (hu) | 2018-07-13 | 2023-01-28 | Richter Gedeon Nyrt | Spirokromán származékok |
| WO2021111124A1 (en) | 2019-12-02 | 2021-06-10 | Storm Therapeutics Limited | Polyheterocyclic compounds as mettl3 inhibitors |
| CN111285792B (zh) * | 2020-03-23 | 2023-05-02 | 三峡大学 | 2-取代吲哚化合物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9903997D0 (sv) * | 1999-11-03 | 1999-11-03 | Astra Ab | New compounds |
| GB0403155D0 (en) * | 2004-02-12 | 2004-03-17 | Vernalis Res Ltd | Chemical compounds |
| RU2010137114A (ru) * | 2008-02-07 | 2012-03-20 | Эбботт Лэборетриз (Us) | Амидные производные как позитивные аллостерические модуляторы и способы их применения |
-
2009
- 2009-04-16 MX MX2010011358A patent/MX2010011358A/es active IP Right Grant
- 2009-04-16 AU AU2009237650A patent/AU2009237650B2/en not_active Ceased
- 2009-04-16 CL CL2009000916A patent/CL2009000916A1/es unknown
- 2009-04-16 EP EP09733402A patent/EP2279184B1/en active Active
- 2009-04-16 JP JP2011504457A patent/JP2011516598A/ja not_active Ceased
- 2009-04-16 CN CN200980123031.3A patent/CN102066357B/zh not_active Expired - Fee Related
- 2009-04-16 ES ES09733402T patent/ES2392796T3/es active Active
- 2009-04-16 BR BRPI0911682A patent/BRPI0911682A2/pt not_active IP Right Cessation
- 2009-04-16 WO PCT/EP2009/054495 patent/WO2009127679A1/en not_active Ceased
- 2009-04-16 JP JP2011504458A patent/JP2011516599A/ja not_active Ceased
- 2009-04-16 ES ES09732038T patent/ES2392795T3/es active Active
- 2009-04-16 US US12/936,408 patent/US8283365B2/en not_active Expired - Fee Related
- 2009-04-16 EP EP09732038A patent/EP2279183B1/en active Active
- 2009-04-16 TW TW098112580A patent/TW201004939A/zh unknown
- 2009-04-16 EA EA201071201A patent/EA018113B1/ru not_active IP Right Cessation
- 2009-04-16 US US12/936,431 patent/US8377941B2/en not_active Expired - Fee Related
- 2009-04-16 AU AU2009237649A patent/AU2009237649B2/en not_active Ceased
- 2009-04-16 CA CA2721630A patent/CA2721630A1/en not_active Abandoned
- 2009-04-16 EA EA201071202A patent/EA017726B1/ru not_active IP Right Cessation
- 2009-04-16 PE PE2009000537A patent/PE20091724A1/es not_active Application Discontinuation
- 2009-04-16 CN CN200980123025.8A patent/CN102066356B/zh not_active Expired - Fee Related
- 2009-04-16 AR ARP090101342A patent/AR071203A1/es not_active Application Discontinuation
- 2009-04-16 KR KR1020107025697A patent/KR20100133016A/ko not_active Withdrawn
- 2009-04-16 BR BRPI0910585A patent/BRPI0910585A2/pt not_active IP Right Cessation
- 2009-04-16 UY UY031769A patent/UY31769A1/es not_active Application Discontinuation
- 2009-04-16 CA CA2725441A patent/CA2725441C/en not_active Expired - Fee Related
- 2009-04-16 WO PCT/EP2009/054493 patent/WO2009127678A1/en not_active Ceased
- 2009-04-16 KR KR1020107025698A patent/KR20100135911A/ko not_active Withdrawn
- 2009-04-16 MX MX2010011359A patent/MX2010011359A/es active IP Right Grant
-
2010
- 2010-09-27 ZA ZA2010/06855A patent/ZA201006855B/en unknown
- 2010-09-27 ZA ZA2010/06856A patent/ZA201006856B/en unknown
- 2010-10-07 IL IL208574A patent/IL208574A/en not_active IP Right Cessation
- 2010-10-07 IL IL208575A patent/IL208575A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20091724A1 (es) | Derivados de indol como moduladores del receptor nicotinico de acetilcolina alfa 7 | |
| PE20060777A1 (es) | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas | |
| DOP2009000133A (es) | Derivados de indol como agonistas de los receptores s1p1 | |
| PE20091173A1 (es) | Derivados de heteroarilo como antagonistas de receptor de orexina | |
| PE20121506A1 (es) | Compuestos triazolopiridinas como inhibidores de c-met | |
| PE20110028A1 (es) | Derivados de isoxazol y su uso como potenciadores de los receptores metabotropicos de glutamato | |
| PE20080275A1 (es) | Derivados de 5h-benzo[4,5]ciclohepta[1,2]piridina como inhibidores de tirosina quinasa | |
| PE20081831A1 (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona | |
| PE20090546A1 (es) | Derivados de imidazol como antagonistas de los receptores de quimioquina ccr-2, ccr-3 y ccr-5 | |
| PE20090884A1 (es) | Compuestos de indol como activadores de glucoquinasa | |
| PE20081316A1 (es) | COMPUESTOS HETEROCICLICOS QUE MODULAN LA ACTIVIDAD DE LA ESTEROIL-CoA-DESATURASA | |
| PE20091842A1 (es) | Pirrolidinonas como activadores de glucoquinasa | |
| PE20051173A1 (es) | Compuestos azabiciclico (3.1.0) hexanos como moduladores de receptores de dopamina d3 | |
| PE20140703A1 (es) | Derivados de heteroarilo como moduladores de nachr alfa 7 | |
| PE20081504A1 (es) | Compuestos de biciclocarboxiamida sustituidos | |
| PE20080889A1 (es) | Aminometil-4-imidazoles | |
| PE20140934A1 (es) | Derivados de pirazol | |
| PE20061150A1 (es) | Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1) | |
| DE602008001983D1 (de) | Pyrrolidinderivate als doppelte nk1/nk3-rezeptorenantagonisten | |
| PE20090622A1 (es) | Nuevos derivados de bencimidazol sustituido | |
| PE20091398A1 (es) | Compuestos biciclicos conteniendo nitrogeno activos en condiciones de dolor cronicas | |
| PE20070491A1 (es) | Compuestos derivados de 9-azabiciclo[3.3.1]nonano como inhibidores de la recaptacion de neurotransmisores de monoamina | |
| PE20060625A1 (es) | Derivados de benzazepina como antagonistas y/o agonistas del receptor h3 de histamina | |
| PE20091649A1 (es) | Derivados de pirrolidinilo | |
| PE20080207A1 (es) | DERIVADOS DE 1-N-AMINO-2-IMIDAZOLIDINONAS COMO INHIBIDORES DEL CANAL DE POTASIO Kv1.5 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |